These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6207341)

  • 1. [Non-isotopic method of determining prolylhydroxylase activity in the blood].
    Mansurova ID; Nabidzhanova EN
    Lab Delo; 1984; (7):392-5. PubMed ID: 6207341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
    Leonardi S; La Spina M; La Rosa M; Schilirò G
    Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic procedures for liver fibrosis.
    Rojkind M; Kershenobich D
    Lab Res Methods Biol Med; 1983; 7():73-87. PubMed ID: 6312231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity diagnosis of liver fibrosis and liver cirrhosis].
    Langness U
    Med Klin; 1977 Mar; 72(12):492-6. PubMed ID: 190524
    [No Abstract]   [Full Text] [Related]  

  • 6. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
    Bolarin DM; Andy JJ
    Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prolyl-hydroxylase: only a marker of hepatic damage?
    Tamaro G; Pozzato G; Moretti M
    Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic prolyl hydroxylase activity in human liver disease.
    McPhie JL
    Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of blood antioxidant enzymes in alcoholic cirrhosis.
    Chari S; Gupta M
    Indian J Physiol Pharmacol; 2003 Jul; 47(3):343-6. PubMed ID: 14723322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there any connection between angiotensin converting enzyme activity and liver cirrhosis of alcoholic genesis?].
    Marusić M; Babić Z
    Acta Med Croatica; 2007 Sep; 61(4):365-8. PubMed ID: 18044470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis.
    Khan AJ; Ruwali M; Choudhuri G; Mathur N; Husain Q; Parmar D
    Mutat Res; 2009 May; 664(1-2):55-63. PubMed ID: 19428381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver.
    Raedsch R; Stiehl A; Sieg A; Walker S; Kommerell B
    Gastroenterology; 1983 Dec; 85(6):1265-70. PubMed ID: 6628925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum prolyl hydroxylase values in liver diseases].
    Miyabayashi C; Inoue K; Takahara T; Matsui S; Kojima T; Sasaki H; Ooshima A; Iwata K; Yoshida S
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2181-9. PubMed ID: 3029473
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphism in glutathione-S-transferases: a risk factor in alcoholic liver cirrhosis.
    Khan AJ; Choudhuri G; Husain Q; Parmar D
    Drug Alcohol Depend; 2009 May; 101(3):183-90. PubMed ID: 19157724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma collagen-binding vitronectin activated by heparin and dextran sulfate in chronic liver disease.
    Yamada S; Kobayashi J; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):315-24. PubMed ID: 9387191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenase (E.C. 1.2.1.3) in chronic alcoholic liver diseases.
    Nilius R; Zipprich B; Krabbe S
    Hepatogastroenterology; 1983 Aug; 30(4):134-6. PubMed ID: 6629303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic collagen synthesis in a rat model of cirrhosis, and its modification by colchicine.
    Tanner MS; Jackson D; Mowat AP
    J Pathol; 1981 Nov; 135(3):179-87. PubMed ID: 6275060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating enzyme activities of collagen turnover and undulin in patients with various degrees of schistosomiasis and alcoholic liver cirrhosis.
    Shahin M; Schuppan D; Waldherr R; Savolainen ER; Zalpur F; Rahman HM; el Sahly AM; Abdel Razek SM; el Ruby O; Seitz HK
    Hepatogastroenterology; 1995 Feb; 42(1):22-6. PubMed ID: 7782029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.